Association of<i><scp>HMGB</scp>1</i>and<i><scp>HMGB</scp>2</i>genetic polymorphisms with lung cancer chemotherapy response
Ying Wang(Wannan Medical College), Zhaoqian Liu(Central South University), Juan Chen(Central South University), Yu Zhang(Wannan Medical College), Xiangping Li(Central South University), Hong‐Hao Zhou(Central South University), Hui He(Central South University), Yi Zheng(Chinese Academy of Medical Sciences & Peking Union Medical College), Zi‐Yu Chen(Central South University), Chenyue Qian(Central South University), Ji‐Ye Yin(Central South University), Yilan Fu(Central South University), Kamila Smieszkol(Central South University)
Cited by 32
Related Papers
Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium
|Stem Cell Research & Therapy|2019|294
MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G
|Cancer Letters|2008|216
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆
|Annals of Oncology|2021|212
Mechanisms underlying the therapeutic effects of Qingfeiyin in treating acute lung injury based on GEO datasets, network pharmacology and molecular docking
|Computers in Biology and Medicine|2022|206